Cargando…
Case report of Guillain-Barré Syndrome after COVID BNT162b2 mRNA vaccine()
INTRODUCTION: Guillain-Barré syndrome (GBS) is a rare immune disorder that affects peripheral nerves and the cause is not known completely, but it is associated with infections by viruses or bacteria. CASE REPORT: We report the case of a 23-year-old male patient, a health student, who start 24 hours...
Autores principales: | Sosa-Hernández, Oscar, Sánchez-Cardoza, Sofía |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418342/ http://dx.doi.org/10.1016/j.vacune.2022.05.004 |
Ejemplares similares
-
Reporte de caso de síndrome de Guillain-Barré posterior a la vacuna COVID BNT162b2 mRNA
por: Sosa-Hernández, Oscar, et al.
Publicado: (2022) -
Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine
por: García-Grimshaw, Miguel, et al.
Publicado: (2021) -
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
por: Trimboli, Michele, et al.
Publicado: (2021) -
Beyond neutralization for BNT162b2 mRNA vaccination
por: Damani-Yokota, Payal, et al.
Publicado: (2021) -
Safety and BNT162b2 mRNA COVID-19 vaccination
por: Joob, Beuy, et al.
Publicado: (2021)